NL-OMON30532已完成2 期
The effect of glycopyrronium bromide on hypersalivation in patients with Parkinson's disease: a randomised, cross-over, double-blind, placebo controlled trial. - Glyspar study
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Patients with Parkinson's disease
- •- Age >=18 years
- •- Hypersalivation score >=5 (on a scale from 1-9)
- •- Patient or family is able to score the extent of hypersalivation
排除标准
- •- Hypersensitivity to glycopyrronium bromide, sorbic acid or saccharin sodium
- •- Myasthenia gravis
- •- Tachycardia
- •- Coronary insufficiency
- •- Glaucoma
- •- Pylorus stenosis
- •- Paralytic ileus
- •- Prostate hypertrophy
- •- Pregnancy or lactation
研究者
相似试验
已完成
不适用
The effect of glycopyrronium bromide on hypersalivation in patients with Parkinson's disease: a randomised, cross-over, double blind, placebo-controlled trialParkinsonian patients, hypersalivationNervous System DiseasesExtrapyramidal and movement disordersISRCTN28592111Hospital Medisch Spectrum Twente (The Netherlands)23
已完成
不适用
The effect of glycopyrroniumbromide on hypersalivation in patients with Parkinson's disease: a randomised, cross-over, doubleblind, placebocontrolled trial.Parkinsonian patients with hypersalivationNL-OMON20228M.E.L. Arbouw, Hospital Medisch Spectrum TwenteDepartment of clinical pharmacyP.O. Box 50.0007500 KA EnschedeThe Netherlands24
尚未招募
不适用
Inhaled glycopyrronium on excessive sialorrhea and droolingSialorrhea, drooling, Parkinson Disease.Speekselvloed, kwijlen, Ziekte van ParkinsonNL-OMON27582Medisch Spectrum Twente, Enschede10
已完成
2 期
The effect of INhaled Glycopyrronium bromide on Excessive Sialorrhea and Drooling in Parkinson disease: a dose finding studyNL-OMON45524Medisch Spectrum Twente10
已完成
不适用
Clofibrate in ictereonatal jaundice.Neonatal jaundice, unspecifiedIRCT201008172639N3Shaheed Sadoughi University of Medical Sciences and Health Services60